13 11 20

Information and support

  • Get informed
  • Get support
  • Cut my risk
  • Get involved
  • Research
  • Research home > Beat Cancer Project search > Novel drug delivery approaches to improve the quality of life and survival of patients with multiple myeloma

    Novel drug delivery approaches to improve the quality of life and survival of patients with multiple myeloma

    Dr Krzysztof Mrozik
    • Donor Funding: 240,000
    • Cancer Type: Blood cancers
    • Cancer Stage: Treatment
    • Funded in: 2020
    • Dr Krzysztof Mrozik
      The University of Adelaide

    Multiple myeloma (MM) is an inoperable blood cancer that grows within bones. Drug therapy is integral to the treatment of patients with MM; however, it frequently results in debilitating side effects, negatively impacting quality of life. For instance, while the standard-of-care MM drug bortezomib (VELCADE®) is effective at treating the cancer, many patients are plagued by peripheral neuropathy, a painful and highly debilitating nerve condition affecting the hands and feet. This condition frequently necessitates dose reduction or even treatment cessation, which adversely affects patient survival.

    One approach to minimise the risk of drug side effects is to improve drug delivery to sites of tumour. In this project, I will investigate novel approaches to selectively increase the delivery of commonly used MM drugs to sites of MM tumour, and the utility of these approaches to effectively treat the cancer and reduce drug side effects will be assessed. Firstly, I will utilise agents that transiently disrupt tumour vasculature, enabling the selective enhancement of drug delivery to sites of MM tumour and thereby an increase in effectiveness of low doses of drugs. Secondly, I will utilise state-of-the-art nanoparticles to selectively deliver drugs to sites of MM tumour, thereby minimising the exposure of normal tissues to drugs.
    Ultimately, this project has the potential to reduce the incidence and severity of drug side effects, leading to significantly improved quality of life and survivorship in many patients with MM.

  • Apply for funding

    Apply for funding

    Find out more about applications for funding.

  • Cancer statistics

    Cancer statistics

    Access the latest cancer statistics for South Australia

  • Clinical trials

    Clinical trials

    Access the list of current clinical trials taking place in South Australia.